Biochemical features of ceruloplasmin gene mutations linked to aceruloplasminemia
Tóm tắt
Aceruloplasminemia is a neurodegenerative disease characterized by parenchymal iron accumulation owing to mutations in the ceruloplasmin gene. Ceruloplasmin is expressed in the central nervous system in which most of the ceruloplasmin is located on the surface of astrocytes in a glycosylphosphatidy linositol (GPI)-anchored form. We herein describe the biochemical features of wild-type and mutant GPI-anchored ceruloplasmin. An overexpression of wild-type GPI-anchored ceruloplasmin in Chinese hamster ovary cells led to the formation of aggresomelike inclusions, especially in the presence of proteasome inhibitors. As expected from the properties of aggresomes, the inclusions were colocalized with γ-tubulin and a disruption of microtubules using nocodazole blocked the formation of such inclusions. Aceruloplasminemia-linked mutant proteins failed to form such inclusions even after treatment with proteasomal inhibitors. Animmunofluorescent analysis indicated that the mutant proteins were thus retained in the endoplasmic reticulum (ER), whereas the transfected cells showed a decreased viability. The expression of glucose-regulated protein 78 that is one of the ER stress sensor proteins, and the activity of glucose-regulated protein 78 promoter was upregulated in the cells transfected with the mutants. These findings indicated that when the overexpressed cytoplasmic wild-type cerulop lasmin was not subjected to degradation by the proteasome-ubiquitin system, then the wild-type protein was transported along the microtubules, thus forming inclusions at the microtubule organizing center, whereas the mutant ceruloplasmin failed to form any such inculsions, because the mutant protein might not have been translocated across the ER into the cytoplasm. Therefore, the mutant protein was considered to have accumulated in the ER thus leading to the ER stress, which resulted in cell death.
Tài liệu tham khảo
Askwith C. C. and Kaplan J. (1998) Site-directed mutagenesis of the yeast multicopper oxidase Fet3p. J. Biol. Chem. 273, 22,415–22,419.
Daimon M., Susa S., Ohizumi T., et al. (2000) A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (HypoCPGM). Tohoku J. Exp. Med. 191, 119–125.
Gitlin J. D. (2003) Wilson disease. Gastroenterology 125, 1868–1877.
Gu W. J., Corti O., Araujo F., et al. (2003) The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates. Neurobiol. Dis. 14, 357–364.
Harris Z. L., Durley A. P., Man T. K., and Gitlin J. D. (1999) Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl. Acad. Sci. USA 96, 10,812–10,817.
Harris Z. L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R. T., and Gitlin J. D. (1995) Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl. Acad. Sci. USA 92, 2539–2543.
Hellman N. E. and Gitlin J. D. (2002) Ceruloplasmin metabolism and function. Annu. Rev. Nutr. 22, 439–458.
Hellman N. E., Kono S., Miyajima H., and Gitlin J. D. (2002a) Biochemical analysis of a missense mutation in aceruloplasminemia. J. Biol. Chem. 277, 1375–1380.
Hellman N. E., Kono S., Mancini G. M., Hoogeboom A. J., De Jong G. J., and Gitlin J. D. (2002b) Mechanisms of copper incorporation into human ceruloplasmin. J. Biol. Chem. 277, 46,632–46,638.
Hyun D. H., Lee, M., Halliwell B., and Jenner P. (2003) Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, includingnitrated proteins. J. Neurochem 86, 363–373.
Jeong S. Y. and David S. (2003) Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 278, 27,144–27,148.
Johnsion J. A., Ward C. L., and Kopito R. R. (1998) Aggresomes: a cellular response to misfolded proteins. J. Cell. Biol. 143, 1883–1898.
Keneko K., Nakamura A., Yoshida K., Kametani F., Higuchi K., and Ikeda S. (2002a) Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free. Radic. Res. 36, 303–306.
Keneko K., Yoshida K., Arima K., et al. (2002b) Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia. J. Neuropathol. Exp. Neurol. 61, 1069–1077.
Klomp L. W. and Gitlin J. D. (1996) Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum. Mol. Genet. 5, 1989–1996.
Kchno S., Miyajima H., Takahashi Y., Suzuki H., and Hishida A. (2000) Defective electron transfer in complexes I and IV in patients with aceruloplasminemia. J. Neurol. Sci. 182, 57–60.
Kopito R. R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524–530.
Kopito R. R. and Sitia R. (2000) Agresomes, and Russeli bodies. Symptoms of cellular indigestion? EMBO Rep. 1, 225–231.
Ma J. and Lindquist S. (2001) Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc. Natl. Acad. Sci. USA 98, 14,955–14,960.
Mishra R. S., Bose S., Gu Y., Li R., and Singh N. (2003) Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders. J. Alzheimers Dis. 5, 15–23.
Miyajima H. (2003) Aceruloplasminemia, aniron metabolic disorder. Neuropathology 23, 345–350.
Miyajima H., Kono S., Takahashi Y., and Sugimoto M. (2002) Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains. Blood Cells Mol. Dis. 29, 433–438.
Miyajima H., Fujimoto M., Kohno S., Kaneko E., and Gitlin J. D. (1998) CSF abnormalities in patients with aceruloplasminemia. Neurology 51, 1188–1190.
Miyajima H., Nishimura Y., Mizoguchi K., Sakamoto M., Shimizu T., and Honda N. (1987) Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37, 761–767.
Miyajima H., Adachi J., Kohno S., Takahashi Y., Ueno Y., and Naito T. (2001a) Increased oxysterols associated with iron accumulation in the brains and visceral organs of acaerulop lasminaemia patients. Qjm. 94, 417–422.
Miyajima H., Kono S., Takahashi Y., Sugimoto M., Sakamoto M., and Sakai N. (2001b) Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 57, 2205–2210.
Muqit M. M., Davidson S. M., Payne Smith M. D., et al. (2004) Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. Hum. Mol. Genet. 13, 117–135.
Nadanaka S., Yoshida H., Kano F., Murata M., and Mori K. (2004) Activation of mammalian unfolded protein response is compatible with the quality control system operating in the endoplasmic reticulum. Mol. Biol. Cell 15, 2537–2548.
Nakagawa T., Zhu H., Morishima N., et al. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloidbeta. Nature 403, 98–103.
Patel B. N., Dunn R. J., and David S. (2000) Alternative RNA splicing generates a glycosylphos-phatidylinositol-anchored form of ceruloplasmin in mammalian brain. J. Biol. Chem. 275, 4305–4310.
Patel B. N., Dunn R. J., Jeong S. Y., Zhu Q., Julien J. P., and David S. (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22, 6578–6586.
Sato M. and Gitlin J. D. (1991) Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J. Biol. Chem. 266, 5128–5134.
Shastry B. S. (2003) Neurodegenerative disorders of protein aggregation. Neurochem. Int. 43, 1–7.
Shen J., Snapp E. L., Lippincott-Schwartz J., and Prywes R. (2005) Stable binding of ATF6 to BiP in the endoplasmic reticulum stress response. Mol. Cell. Biol. 25, 921–932.
Tajima K., Kawanami T., Nagai R., Horiuchi S., and Kato T. (1999) Hereditary ceruloplasmin deficiency increases advanced glycation end products in the brain. Neurology 53, 619–622.
Tanaka M., Kim Y. M., Lee G., Junn E., Iwatsubo T., and Mouradian M. M. (2004) Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J. Biol. Chem. 279, 4625–4631.
Taylor J. P., Hardy J., and Fischbeck K. H. (2002) Toxic proteins in neurodegenerative disease. Science 296, 1991–1995.
Urano F., Wang X., Bertolotti A., et al. (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287, 664–666.
Yoshida H., Haze K., Yanagi H., Yura T., and Mori K. (1998) Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucoseregulated proteins. Involvement of basic leucine zipper transcription factors. J. Biol. Chem. 273, 33,741–33,749.
Yoshida K., Kaneko K., Miyajima H., et al., (2000) Increased lipid peroxidation in the brains of aceruloplasminemia patients. J. Neurol. Sci. 175, 91–95.
Yoshida K., Furihata K., Takeda S., et al. (1995) A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9, 267–272.